Skip to main content
Premium Trial:

Request an Annual Quote

Informax Licenses Genomax to Windber Research Institute

NEW YORK, July 31 – Bioinformatics company Informax said Tuesday it had signed a deal to license its Genomax software system to Windber Research Institute.

Under the terms of the deal Informax of Bethesda, Md., will also provide system support and professional services to Windber, a research laboratory for the Walter Reed Army Medical Center’s breast cancer project.

The Windber Research Institute is a national tissue repository with links to a functional genomics and proteomics laboratory.

Informax has more than 30 biotech customers for GenoMax, which is designed to work with several types of genomics and proteomics data.

Financial terms of the deal were not disclosed.

 

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.